Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis.

Hoffman, T W; van Moorsel, C H M; Kazemier, K M; Biesma, D H; Grutters, J C; van Kessel, D A

Hoffman, T W; van Moorsel, C H M; Kazemier, K M; Biesma, D H; Grutters, J C; van Kessel, D A.

Afiliação

Hoffman TW; Department of Pulmonology, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein, The Netherlands. t.hoffman@antoniusziekenhuis.nl.
van Moorsel CHM; Department of Pulmonology, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein, The Netherlands.
Kazemier KM; Division of Heart and Lungs, University Medical Centre, Utrecht, The Netherlands.
Biesma DH; Department of Pulmonology, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein, The Netherlands.
Grutters JC; Division of Heart and Lungs, University Medical Centre, Utrecht, The Netherlands.
van Kessel DA; Centre for Translational Immunology, University Medical Centre, Utrecht, The Netherlands.

Lung ; 199(6): 667-676, 2021 12.

Article em En | MEDLINE | ID: mdl-34714393

Assuntos

Fibrose Pulmonar Idiopática; Humanos; Pulmão; Linfócitos; Neutrófilos; Estudos Retrospectivos

Palavras-chave

Acute exacerbation; Idiopathic pulmonary fibrosis; Immune status; Immunodeficiency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google